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We report a consanguineous family in which schizophrenia 
segregates in a manner consistent with recessive inher-
itance of a rare, partial-penetrance susceptibility allele. 
From 4 marriages between 2 sets of siblings who are half 
first cousins, 6 offspring have diagnoses of psychotic dis-
order. Homozygosity mapping revealed a 6.1-Mb homo-
zygous region on chromosome 13q22.2-31.1 shared by all 
affected individuals, containing 13 protein-coding genes. 
Microsatellite analysis confirmed homozygosity for the 
affected haplotype in 12 further apparently unaffected 
members of the family. Psychiatric reports suggested an 
endophenotype of milder psychiatric illness in 4 of these 
individuals. Exome and genome sequencing revealed no po-
tentially pathogenic coding or structural variants within the 
risk haplotype. Filtering for noncoding variants with a minor 
allele frequency of <0.05 identified 17 variants predicted to 
have significant effects, the 2 most significant being within 
or adjacent to the SCEL gene. RNA sequencing of blood 
from an affected homozygote showed the upregulation of 
transcription from NDFIP2 and SCEL. NDFIP2 is highly 
expressed in brain, unlike SCEL, and is involved in deter-
mining T helper (Th) cell type 1 and Th2 phenotypes, which 
have previously been implicated with schizophrenia.
Key words:  consanguineous/endophenotype/homozygosity/ 
chromosome 13q/risk haplotype
Introduction
The substantial heritability of schizophrenia (60%–
80%)1–4 is partly accounted for by common risk variants 
detected by genome-wide association studies (GWAS),5,6 
rarer copy number variants (CNVs),7,8 and high pene-
trance alleles in genes such as SETD1A.9,10 Further ultra-
rare variants could be shared by families11,12 or small, 
endogamous communities but would be missed in general 
population association studies because of their extremely 
low overall frequency.
Recessive alleles with a major effect on psychosis risk, 
if  they exist, are likely to be enriched in affected individ-
uals from populations with high consanguinity. This is 
because such progeny may have inherited 2 copies of the 
relevant variant (maternal and paternal) from a recent 
common ancestor.13 Evidence for such alleles comes from 
the observation that schizophrenia risk increases with 
consanguinity.13–15 Analysis of consanguineous families 
and cases with psychotic disorder has shown increased 
homozygosity16 and highlighted candidate genes and 
chromosomal regions of interest.17–19
The Pakistani population of West Yorkshire in the 
north of England comprised around 142 000 individuals 
in the 2011 census, the majority originating from Mirpur 
in Azad Kashmir, Pakistan. Around 37% of marriages in 
this community are between first cousins,20 resulting in 
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unions that are both endogamous and consanguineous, 
with high background autozygosity (homozygosity-by-
descent) and increased recessive disease due to enrich-
ment for homozygosity of recessive alleles.21 There is an 
elevated prevalence of schizophrenia and other psychoses 
in the West Yorkshire Pakistani population.22 Like other 
migrant groups, they are subject to environmental risk 
factors such as low birth weight23 and risks associated 
with residence in deprived inner city areas.24 However, 
we hypothesized that part of the increase in risk could 
be due to recessive alleles of major effect predisposing to 
psychosis. We, therefore, looked within this community 
for consanguineous families with multiple cases of schiz-
ophrenia, which would support this assertion. Here, we 
report an analysis of one such family.
Methods
A more detailed description of methods used in this study 
is included in the supplementary material. 
Ascertainment and Diagnosis
Participants were recruited from the West Yorkshire 
Pakistani population, with ethical approval via Research 
Ethics Committee applications 08/H1313/17, 10/
H1313/37, 11/H1310/1, 09/H1302/61, and 13/YH/0149 
covering different aspects of the work. Clinical assess-
ments were based on Schedules for Clinical Assessment 
in Neuropsychiatry (SCAN)25 or Positive and Negative 
Syndrome Scale (PANSS)26 interviews and review of case 
records.
Homozygosity Mapping and Linkage Analysis
Homozygosity mapping was performed on Affymetrix 
6.0 SNP (single nucleotide polymorphism) array data or 
SNP genotypes derived from whole exome sequencing 
(WES), using AgileMultiIdeogram (http://dna.leeds.
ac.uk/agile/AgileMultiIdeogram/). Four chromosome 
13q microsatellite markers were genotyped in 24 family 
members for whom DNA was available. Multipoint par-
ametric linkage analysis was carried out using Superlink 
on-line (http://cbl-hap.cs.technion.ac.il/superlink-snp/). 
Nonparametric linkage was assessed using SimWalk 2.
Whole Exome Sequencing
WES was performed using SureSelect Human All Exon 
V6 reagent (Agilent Technologies), with sequence data 
generated on a HiSeq 3000 (Illumina). Sequences were 
processed in SAM/BAM format using SAMtools27 and 
the Genome Analysis Toolkit (GATK).28 Synonymous 
variants, variants more than 2 base pairs (bp) beyond 
the splice junction, and those present in the single nucle-
otide polymorphism database (dbSNP) 146, the exome 
aggregation consortium (ExAC) v.0.3.1, or the genome 
aggregation database (gnomAD) v2.0 with a minor allele 
frequency (MAF) ≥5% were excluded. 
Whole Genome Sequencing 
Whole genome sequencing (WGS; 150-bp paired-end) 
was performed on an Illumina HiSeqX 10 sequencer 
(Edinburgh Genomics). Variants in the shared homo-
zygous region were called in vcf format and filtered to 
exclude those with MAF ≥ 0.05 in gnomAD. Manual in-
spection of reads across the homozygous region was per-
formed using the Integrative Genomics Viewer (IGV).29
Transcriptional Analysis by RNA Sequencing
Peripheral blood was collected using PAXgene blood 
RNA tubes, and RNA extracted using a PAXgene RNA 
extraction kit, with quality confirmed on a Bioanalyzer 
(Agilent). Libraries were prepared using TruSeq RNA 
sample preparation Kit v2 and sequenced on a HiSeq3000 
(Illumina). Genes were called as differentially expressed 
if  Padj < .05 and they had an absolute log
2
 fold change 
(FC) of ≥1.
Results
Family Structure and Phenotype
The extended family studied (figure 1) consists of 4 nu-
clear families formed by intermarriages among 2 sets of 
siblings who are themselves first half  cousins. Six family 
members have Diagnostic and Statistical Manual of 
Mental Disorders, 5th ed. (DSM-5)30 psychotic disorder 
diagnoses, based on consensus diagnoses of 2 psychiat-
rists: 5 have schizophrenia and 1 has other psychotic dis-
order, the latter with a history of delusions and manic 
symptoms. The onset of psychotic symptomatology 
occurred in the late teens or early twenties. Initially, af-
fected individuals presented with auditory hallucinations, 
paranoid delusions, and formal thought disorder. Later, 
they developed negative symptoms and cognitive decline. 
Males showed exacerbation of symptoms after taking 
cannabis, but females did not take cannabis.
Homozygosity Mapping
Cytogenetic analysis of  individual IV9 revealed a normal 
karyotype. Affymetrix 6.0 SNP genotypes were gener-
ated for IV4, IV5, IV9, and IV11, while SNP genotypes 
were extracted from WES of IV6 and IV14. Autozygosity 
mapping in these individuals (figure 2) revealed a single 
shared homozygous 6.1-Mb region on chromosome 
13q. A  homozygous region shared by chance across 4 
sibships is highly unlikely. This observation, therefore, 
strongly suggests the segregation of a recessive, partial-
penetrance risk allele. The region is bounded by SNPs 
rs17716584 (13q22.2) and rs7997648 (13q31.1) and con-
tains 13 protein-coding genes: KCTD12, ACOD1, CLN5, 
FBXL3, MYCBP2, SCEL, SLAIN1, EDNRB, POU4F1, 
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Fig. 1. Pedigree and haplotype analysis. Four generation pedigree described in this study, with generation IV consisting of 4 nuclear 
families resulting from the marriage of half  first cousins in generation III. Clear and shaded symbols denote unaffected and affected 
individuals, respectively. Double lines denote consanguinity. For those family members for whom DNA was available, a haplotype of 4 
microsatellite markers on chromosome 13q22.3-31.1 is given below each individual, in centromeric to telomeric order. The risk haplotype 
is shaded black, while the only other haplotype observed is hatched. 
Fig. 2. Homozygosity mapping. (a) Locations of homozygous regions identified in SNP or WES data from the 6 individuals with 
schizophrenia or “other psychotic disorder,” plotted against a circular ideogram of chromosomes 1–22 using the AgileMultiIdeogram 
software. SNP data for individuals IV4, 5, 9, and 11 and WES data for individual IV6 and 14, in order from the outer to the inner circles, 
are displayed as white circular bands in the center of the ideogram. Homozygous regions in each family member are shaded, while the 
homozygous region (Chr13: 76,483,001-82,585,713bp in hg19) shared by all family members is highlighted in black. (b) Homozygosity 
on chromosome 13q in the 6 affected individuals generated with the program SNPviewer. Each bar is a plot of the entire length of 
chromosome 13 in a single individual, with homozygous SNPs denoted by a black line and heterozygous SNPs by a lightly shaded 
line. The shared homozygous region appears as a black area shared by all 6 individuals. (c) 13q locus graphic displaying the genes and 
transcripts in the homozygous region.
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RNF219, RBM26, NDFIP2, and SPRY2. The Reference 
Sequence (RefSeq) database also documents 9 long 
intergenic nonprotein coding transcripts, 6 antisense 
transcripts, a microRNA, a pseudogene, and a putative 
gene (figure 2). The region also contains SNP rs9545047, 
which attained genome-wide significance in 1 schizo-
phrenia GWAS31 and in the recent GWAS meta-analysis.5 
Affected individuals are all homozygous for the at-risk 
A allele for SNP rs9545047.
Haplotypes of 4 microsatellite markers on chromosome 
13q22.3-31.1 in family members are shown in figure  1. 
Allele frequency estimates from 27 unrelated Pakistanis 
suggest that the haplotype shared by affected individuals 
in the homozygous 13q region is rare in the Pakistani pop-
ulation (supplementary table S1). Analysis revealed that 
the 13q22.2-31.1 region is also homozygous in 12 appar-
ently unaffected individuals in generations III and IV of 
the family. This suggests 33% (6/18) penetrance in homo-
zygotes for the risk haplotype. Four siblings and 2 parents 
are heterozygous for the 13q risk haplotype and none are 
affected. A logarithm of the odds (LOD) score was calcu-
lated for linkage of the homozygous microsatellite haplo-
type with psychosis in the family using the allele frequencies 
in supplementary table S1. Parametric linkage analysis as-
suming a penetrance for the risk haplotype of zero in het-
erozygotes and 33% in homozygotes gave a LOD score of 
3.02. Nonparametric linkage analysis gave a LOD score of 
>0.48 across all markers with a peak of 0.49 at D13S170.
Further Phenotyping
Psychiatric screening of family members without psy-
chotic disorders revealed 1 had anxiety symptoms, 2 had 
depression, and 1 had a history of self-harm. These 4 
were all homozygous for the risk haplotype.
Variant Screening by WES and WGS
WES in 3 affected homozygotes (IV6, IV9, and IV14) 
confirmed the shared homozygous region but revealed 
no potentially pathogenic protein-coding variants within 
it. WGS in IV11 revealed 5721 variants in the 6.1-Mb 
shared homozygous region. Excluding those with MAF 
> 0.05 in gnomAD and dbSNP146 and with a read depth 
of <2 reduced this to 183 variants (supplementary table 
S2). Seventeen of these variants were predicted to have 
a significant functional effect using the DeepSEA algo-
rithm32 (supplementary table S3), including 2 with func-
tional significance scores <0.01, 1 immediately upstream, 
and the other in an intron of the SCEL gene.
CNVs were neither detected by ExomeDepth33 nor ob-
served via IGV within the shared homozygous region in 
WES from IV6, 9, and 14. No large structural variants 
were identified within the shared homozygous region in 
Manta analysis34 of  WGS from IV11. Small indels identi-
fied in WGS were the same as or similar to variants present 
in the Database of Genomic Variation (DGV) and are, 
therefore, unlikely to be pathogenic. ExomeDepth anal-
ysis in WES from IV6, 9, and 14 also excluded large struc-
tural variants in other genomic regions reported to have 
genome-wide significance for association of CNVs with 
schizophrenia.7
Transcriptome Analysis
RNA sequencing (RNA Seq) was carried out on cDNA 
from blood lymphocytes from a single affected individual 
(IV6) and 3 age, sex, and ethnically matched controls. 
Differential expression analysis using the package DSeq235 
revealed significant differences in the expression of 6 of 
the 13 genes in the shared homozygous region, with the 
upregulation of NDFIP2 and SCEL as the most signifi-
cant FCs observed (supplementary figures S2 and S3).
To determine whether SNPs within the homozy-
gous region might be expression quantitative trait loci 
(e-QTLs) altering expression of a gene elsewhere, we 
examined the Gtex combined e-QTL track in the UCSC 
Genome Browser. Other than genes in the region, only 
LMO7 and UCHL3, immediately proximal, were affected 
by e-QTLs in it, and neither were significantly altered in 
the above analysis. We then performed cis-eQTL analysis 
in genotype data from homozygotes with the GGtools 
Bioconductor package, but no linked cis-elements were 
discovered using a 5% false discovery rate threshold. 
Discussion
Phenotypic, genetic, and transcriptomic analyses sug-
gest that multiple cases of schizophrenia in an extended 
family are at least in part caused by a recessively inherited, 
partial-penetrance susceptibility allele or haplotype on 
chromosome 13q22-31. Support for the existence of a re-
cessive schizophrenia risk locus in this family comes from 
the observation of affected individuals in each of 4 nu-
clear families formed by marriages between 2 sets of sib-
lings who are first half  cousins. This inheritance pattern is 
considered predictive of Mendelian recessive inheritance 
in other conditions.
However, apparent recessive inheritance in a single 
family could be coincidental in the context of  this mul-
tifactorial disorder. We, therefore, sought further sup-
port for the existence of  a partial-penetrance recessive 
schizophrenia risk locus in this family. This hypothesis 
predicts that all 6 affected family members, separated 
by 22 meioses from the common ancestor, will share a 
single homozygous region. Such a region would oth-
erwise be highly unlikely given the complexity of  the 
family structure and genetic distance between the in-
dividuals and sibships involved. Homozygosity map-
ping confirmed a single shared 6.1-Mb homozygous 
region on chromosome 13q22.2-31.1, between SNPs 
rs17716584 and rs7997648. This observation further 
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supports the hypothesis of  a high penetrance recessive 
locus, but quantification of  its statistical significance 
is not possible due to the high endogamy and back-
ground homozygosity in the UK Pakistani popula-
tion.21 Homozygosity mapping in a similar population, 
using WES data from 80 Qataris with schizophrenia 
(data not shown), revealed no enrichment for homo-
zygosity at 13q22.3-31.1, suggesting that 13q homozy-
gosity is not common in individuals with schizophrenia 
from other consanguineous populations.
Parametric linkage analysis between 13q markers and 
psychotic disorder in the family using a partial-penetrance 
recessive model gave a LOD score of 3.02, again sup-
porting the hypothesis. Nonparametric linkage analysis 
gave a much lower score due to the lack of inferred data 
from the upper branches when analyzed without a reces-
sive consanguineous model, but the pedigree shown in 
figure 1 strongly supports this model.
The 12 individuals homozygous for the 13q haplotype 
who do not have a psychotic disorder could be considered 
evidence against a 13q risk haplotype. However, other 
mental health problems were documented in 4 of the 12, 
pointing to a spectrum of severity in carriers for the risk 
haplotype. Homozygotes exhibited phenotypes ranging 
from being apparently unaffected (n = 8), through milder 
mental health problems (n  =  4), to the most severely 
affected individuals who have psychosis (n  =  6). This 
may indicate that the 13q risk haplotype acts in concert 
with environmental and other genetic factors, with can-
nabis use a possible contributory factor in male family 
members.36
There is additional support in the literature for a schiz-
ophrenia susceptibility locus on 13q22-31. A GWAS of 
schizophrenia in Ashkenazi Jews31 found an associa-
tion with SNP rs9545047 (risk allele A global frequency 
0.73), adjacent to the RBM26 and NDFIP2 genes within 
the shared homozygous region, which was confirmed in 
the latest GWAS meta-analysis.5 This is the only SNP 
currently associated with schizophrenia on chromo-
some 13. In addition, a GWAS in the Chinese popula-
tion found that SNP rs2073831 in KCTD12, also within 
the shared homozygous region, was significantly asso-
ciated with bipolar disorder (risk allele T global allele 
frequency 0.36).37 The homozygous 13q haplotype seg-
regating in the family described includes the high-risk 
alleles for both of  these SNPs, which may contribute to 
risk in the family. Linkage studies in multiplex families 
also provided evidence suggestive of  linkage to this ge-
nomic region for both schizophrenia and bipolar dis-
order.38–40 Furthermore, a microdeletion encompassing 
the protein-coding genes RBM26, NDFIP2, and 
SPRY2 was identified in a fetus with macrocephaly and 
macroglossia, suggesting a role for these genes in brain 
development.41
WES revealed neither rare protein-coding nor 
splice variants within this region. WGS identified 183 
noncoding variants with MAF < 0.05, 17 of  which are 
predicted to have a functional effect, the 2 most signif-
icant being within or adjacent to the SCEL gene. RNA 
seq in blood from an affected individual showed sig-
nificant differences from controls in the expression of 
several genes in the interval, with the upregulation of 
transcription from the SCEL gene as the second most 
significant FC observed. SCEL encodes sciellin, not an 
obvious schizophrenia candidate gene as it is expressed 
almost exclusively in the skin, tongue, and tonsils, and 
functions in assembling the cornified envelope of  mam-
malian keratinizing tissues. Furthermore, no significant 
skin abnormalities were noted in homozygotes for the 
risk haplotype.
NDFIP2 was the most significantly upregulated tran-
script in blood from a homozygous affected individual. 
It encodes the NEDD4 family-interacting protein 2, in-
volved in protein trafficking and ubiquitination. It is 
a stronger candidate for involvement in schizophrenia 
since it is highly expressed in the brain; lies within a 
haplotype block that includes schizophrenia-associated 
SNP rs9545047; was deleted in a fetus with brain abnor-
malities42; and is subject to rigorous constraint against 
missense or loss of  function variants according to the 
gnomAD database. Furthermore, NDFIP2 is involved 
in the early differentiation of  T helper (Th) cell sub-
types Th1 and Th242. Alterations of  Th1-like cell-me-
diated and Th2-like antibody-related immune responses 
have been documented in schizophrenia and major 
depression.43
However, other genes in the region cannot be excluded, 
and several have well-defined roles in neuronal develop-
ment and function.44–47 Furthermore, the present study 
is limited because transcriptional data are available only 
from blood RNA, there are a limited number of biolog-
ical replicates available, and antipsychotic medication has 
a potential impact on transcription.48
In summary, we report a large family in which mul-
tiple individuals are affected with schizophrenia, giving 
the appearance of  recessive inheritance of  an allele 
of  major effect. Homozygosity mapping identified a 
region of  chromosome 13q shared by all affected in-
dividuals and by many apparently unaffected relatives. 
Further clinical examination revealed evidence for an 
endophenotype of  milder psychiatric illness in several 
further homozygous individuals previously thought 
to be unaffected. No likely pathogenic-coding vari-
ants were identified, but transcriptomic analyses and 
other evidence highlight NDFIP2 as a strong candi-
date, possibly through its involvement in Th1 and Th2 
differentiation.
Supplementary Material
Supplementary material is available at Schizophrenia 
Bulletin.
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